Founding Partner
A life sciences patent lawyer helps pharmaceutical, biotech, and medical device companies protect innovations that standard patent strategies are not built to handle. The key challenges include patentable subject matter hurdles, FDA timeline management, crowded prior art fields, and enforcement against generic manufacturers.
A life sciences patent lawyer helps biotech founders, pharmaceutical companies, and medical device manufacturers navigate patentability hurdles, FDA timelines, and enforcement challenges that generic patent strategies simply do not address.
Life sciences patent law is not like other patent law. The science is harder, the regulatory timeline is longer, and the stakes are higher. If you are developing a new drug, a medical device, or a biotechnology platform, a life sciences patent lawyer is not a nice-to-have. It is the difference between owning your innovation and watching someone else profit from it.
Richard Gearhart, founding partner of Gearhart Law, has spent nearly 30 years helping life sciences companies build patent portfolios that hold up, attract investment, and support licensing and commercialization strategies. The challenges in this space are specific, and the solutions have to match.
Why Life Sciences Patents Are Different from Other Patent Areas
Most patent applicants are working with a product they can describe clearly, demonstrate quickly, and bring to market without waiting for a regulator to sign off. Life sciences are different on every one of those counts.
The FDA Timeline Problem
A pharmaceutical company might spend 10 to 15 years and over a billion dollars bringing a new drug from discovery to approval. A patent is filed early in that process, which means a significant portion of the 20-year patent term gets consumed before the product ever reaches patients.
Congress addressed this through patent term extensions under the Hatch-Waxman Act, which allows pharmaceutical patent holders to apply for extensions of up to five years to compensate for time lost during FDA review.
Time management here is critical. Filing at the wrong time, or failing to apply for an extension, can cost years of exclusivity worth hundreds of millions of dollars.
The Patentable Subject Matter Hurdle
In life sciences, the line between a patentable invention and an unpatentable natural phenomenon is not always obvious. The Supreme Court’s decision in Mayo v. Prometheus made it harder to patent diagnostic methods and certain biotechnology applications.
As a general rule, naturally occurring substances cannot be patented. A gene as it exists in nature, a naturally occurring protein, or a biological process that happens without human intervention.
What can be patented is a meaningful human innovation that goes beyond discovery. A novel method of using a gene. A synthetic compound. A new diagnostic process with a specific application.
Proving Utility for Pharmaceutical Compounds
For pharmaceutical inventions, your patent application must demonstrate that the compound has a specific, substantial, and credible utility under USPTO MPEP § 2107.
- Specific: the utility must be tied to the particular compound claimed, not a vague statement like “biological activity” or “may prove useful in treating unspecified disorders”
- Substantial: the invention must provide a real-world benefit in its current form, not require further research to confirm whether it works
- Credible: the assertion must be believable to someone skilled in the field based on the evidence provided
Early-stage compounds where the therapeutic use is speculative may face rejection. Your application strategy has to be built around what the science can actually support at the time of filing, not where you hope it will go.
What Life Sciences Companies Can Actually Patent
The range of protectable innovations in life sciences is broader than many founders realize. Here is what a life sciences patent lawyer can help you protect:
Pharmaceutical and Drug Patents
- New chemical entities and drug compounds
- Formulations that improve delivery, stability, or bioavailability
- Methods of treatment using known compounds in new applications
- Manufacturing processes for producing pharmaceutical ingredients
- Combination therapies and dosing regimens
Medical Device Patents
- Novel device designs and structural improvements
- Methods of using a device to achieve a specific clinical outcome
- Software-driven features in connected or implantable devices
- Manufacturing methods and material innovations
Biotechnology Patents
- Genetically engineered organisms and modified cell lines
- Novel antibodies, proteins, and biologics
- CRISPR and gene editing methods with specific technical applications
- Diagnostic assays and testing methods tied to specific technical steps
If you are building in life sciences and have not mapped your patent strategy yet, the patent attorneys at Gearhart Law can help you identify what is protectable, when to file, and how to build a portfolio that supports your business goals. Reach out for a free half-hour consultation.
The Biggest Patent Challenges Life Sciences Companies Face
Crowded Prior Art Fields
In pharma and biotech, someone has probably already published something close to what you built. The prior art field is crowded, and proving your invention is truly novel takes more than a keyword search. A professional patent search is not optional in life sciences. It is the foundation of a defensible application.
Patent Prosecution and Office Actions
Life sciences patent applications routinely receive office actions from the United States Patent and Trademark Office (USPTO), including rejections based on prior art, patentable subject matter, or written description requirements. Responding effectively requires both scientific credibility and legal precision. Patent prosecution in this space is not a one-time filing. It is an ongoing process that can span years and require multiple rounds of amendment and argument.
Enforcing Patents Against Generic Manufacturers
For pharmaceutical patents, enforcement often means responding to a Paragraph IV certification, which is a notice from a generic manufacturer challenging the validity of your patent as part of a generic drug application. If you file suit within 45 days, FDA approval of the generic is generally postponed for up to 30 months while the dispute is resolved.
Getting this wrong can cost years of protected revenue. That’s a big part of what makes patent litigation in the life sciences space so high-stakes.
International Patent Protection
Healthcare is a global market. A drug approved in the U.S. needs patent protection in Europe, Asia, and every market where it will be sold or licensed.
International patent filings through the Patent Cooperation Treaty allow life sciences companies to file a single application that preserves rights in over 150 countries, buying time to evaluate which markets to enter before committing to individual national filings.
Why New Jersey Is a Life Sciences Patent Hub
New Jersey is home to one of the largest concentrations of pharmaceutical and biotechnology companies in the world. Johnson & Johnson, Pfizer, Becton Dickinson, and hundreds of biotech startups operate in or near the state. This concentration of innovation makes IP strategy a competitive priority, rather than just a legal formality.
Federal patent law governs all U.S. patents, and life sciences patent disputes are litigated in federal district court. For New Jersey companies, that means the United States District Court for the District of New Jersey, which has significant experience with pharmaceutical patent litigation, including Hatch-Waxman cases.
Beyond federal court, New Jersey companies also need to think carefully about trade secret protection for compounds and processes that are not yet patented or that may be better protected by keeping them confidential. A layered strategy combining patents, trade secrets, and licensing agreements is often the most effective approach for life sciences companies in this market.
Work With a Life Sciences Patent Lawyer Who Understands the Science
Patent strategy in life sciences requires attorneys who understand the biology, the chemistry, and the regulatory framework, not just the legal process. A generic approach to patent drafting leaves gaps that competitors will find.
Gearhart Law works with pharmaceutical, biotechnology, and medical device companies throughout New Jersey, including Summit, Millburn, New Brunswick, Westfield, and beyond. Our team is made up of attorneys and patent agents with advanced scientific degrees, includingT. Benjamin Schroeder, Ph.D.,Elizabeth Gearhart, Ph.D., and Joe Runge, JD, MS, who understand what you are building at a technical level.
If you are ready to build a patent strategy for your life sciences innovation, reach out for a free half-hour consultation at 908.273.0700 or leave us your details.
Frequently Asked Questions About Life Sciences Patent Law
1. What does a life sciences patent lawyer do?
A life sciences patent lawyer helps pharmaceutical, biotechnology, and medical device companies protect their innovations through patent filings, prosecution, licensing, and enforcement. This includes identifying what is patentable, drafting claims that hold up to scrutiny, responding to USPTO office actions, and litigating patents when competitors infringe them.
2. Can you patent a new drug compound?
Yes. New chemical entities with a specific, substantial, and credible therapeutic utility may be patentable as utility patents. You can also patent formulations, delivery methods, manufacturing processes, and methods of treatment. Naturally occurring substances cannot be patented on their own, but meaningful human innovations built on them can be.
3. How long does a pharmaceutical patent last?
A standard utility patent lasts 20 years from the filing date. Because pharmaceutical companies often file early in the development process, significant time can be consumed before FDA approval. Patent term extensions under the Hatch-Waxman Act may allow for up to five additional years to compensate for regulatory review time.
4. What is the biggest patent challenge in biotechnology?
The biggest challenge is clearing the patentable subject matter hurdle. After notable Supreme Court decisions (specifically Mayo v. Prometheus), diagnostic methods and naturally occurring biological phenomena face heightened scrutiny. The key is demonstrating that your invention involves a meaningful technical step beyond simply observing a natural law. A legal patentability opinion from an experienced attorney is the right starting point.
5. Can medical device software be patented?
Yes, in many cases. Software that controls a medical device, processes diagnostic data, or enables a specific clinical function may be patentable as part of a larger device claim or as a standalone method claim. The analysis depends on how the claims are drafted and whether the software is tied to a specific technical application.
6. Do I need to wait for FDA approval before filing a patent?
No, waiting is usually the wrong move. A patent application should be filed as early as possible, before any public disclosure of the invention. FDA approval is a separate process and has nothing to do with patent filing. Filing early locks in your priority date and starts the 20-year term. Patent term extensions can help recover time lost during the regulatory review period.